KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Tax Rate (2016 - 2025)

Historic Tax Rate for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to 130.0%.

  • Teva Pharmaceutical Industries' Tax Rate fell 1186600.0% to 130.0% in Q4 2025 from the same period last year, while for Dec 2025 it was 12.47%, marking a year-over-year increase of 1803800.0%. This contributed to the annual value of 14.72% for FY2025, which is 379300.0% up from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Tax Rate of 130.0% as of Q4 2025, which was down 1186600.0% from 33.13% recorded in Q3 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Tax Rate peaked at 76.4% during Q2 2022, and registered a low of 256.1% during Q2 2024.
  • Over the past 5 years, Teva Pharmaceutical Industries' median Tax Rate value was 0.76% (recorded in 2022), while the average stood at 9.38%.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Tax Rate crashed by -2578300bps in 2024 and then soared by 2176700bps in 2025.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Tax Rate stood at 13.71% in 2021, then plummeted by -192bps to 12.57% in 2022, then soared by 81bps to 2.34% in 2023, then tumbled by -385bps to 11.34% in 2024, then tumbled by -1047bps to 130.0% in 2025.
  • Its Tax Rate stands at 130.0% for Q4 2025, versus 33.13% for Q3 2025 and 38.42% for Q2 2025.